{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T02:16:10Z","timestamp":1788401770083,"version":"build-2803163510"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T00:00:00Z","timestamp":1610064000000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001288","name":"Parkinson's Disease Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001288","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006309","name":"American Parkinson Disease Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006309","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.jbc.2021.100273","type":"journal-article","created":{"date-parts":[[2021,1,10]],"date-time":"2021-01-10T23:27:40Z","timestamp":1610321260000},"page":"100273","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Genetic deletion of Polo-like kinase 2 reduces alpha-synuclein serine-129 phosphorylation in presynaptic terminals but not Lewy bodies"],"prefix":"10.1016","volume":"296","author":[{"given":"Leah J.","family":"Weston","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa L.","family":"Stackhouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kateri J.","family":"Spinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydney W.","family":"Boutros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth P.","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7283-697X","authenticated-orcid":false,"given":"Valerie R.","family":"Osterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelvin C.","family":"Luk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Raber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamily A.","family":"Weissman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8833-6542","authenticated-orcid":false,"given":"Vivek K.","family":"Unni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2021.100273_bib1","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3389\/fneur.2019.00218","article-title":"Parkinson's disease and the Environment","volume":"10","author":"Ball","year":"2019","journal-title":"Front Neurol."},{"key":"10.1016\/j.jbc.2021.100273_bib2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/nan.12298","article-title":"Review: Sporadic Parkinson's disease: Development and distribution of alpha-synuclein pathology","volume":"42","author":"Del Tredici","year":"2016","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.jbc.2021.100273_bib3","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/mds.26605","article-title":"Neuropathological basis of nonmotor manifestations of Parkinson's disease","volume":"31","author":"Adler","year":"2016","journal-title":"Mov Disord."},{"key":"10.1016\/j.jbc.2021.100273_bib4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.neuron.2006.09.026","article-title":"Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: New targets for drug discovery","volume":"52","author":"Lee","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.jbc.2021.100273_bib5","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/bs.ircmb.2015.07.007","article-title":"Intracellular dynamics of synucleins: \"Here, there and Everywhere\"","volume":"320","author":"Surguchov","year":"2015","journal-title":"Int. Rev. Cell Mol Biol"},{"key":"10.1016\/j.jbc.2021.100273_bib6","doi-asserted-by":"crossref","first-page":"29739","DOI":"10.1074\/jbc.M600933200","article-title":"Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease","volume":"281","author":"Anderson","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2021.100273_bib7","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00401-008-0409-8","article-title":"Evaluation of alpha-synuclein immunohistochemical methods used by invited experts","volume":"116","author":"Beach","year":"2008","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jbc.2021.100273_bib8","doi-asserted-by":"crossref","first-page":"724","DOI":"10.2174\/187152711797247858","article-title":"Kinases as targets for Parkinson's disease: From genetics to therapy","volume":"10","author":"Vancraenenbroeck","year":"2011","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.jbc.2021.100273_bib9","first-page":"872","article-title":"Phosphorylation does not prompt, nor prevent, the formation of alpha-synuclein toxic species in a rat model of Parkinson's disease","volume":"18","author":"Azeredo da Silveira","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jbc.2021.100273_bib10","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/NEN.0b013e3181a24b53","article-title":"Alpha-synuclein S129 phosphorylation mutants do not alter nigrostriatal toxicity in a rat model of Parkinson disease","volume":"68","author":"McFarland","year":"2009","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.jbc.2021.100273_bib11","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1093\/hmg\/dds058","article-title":"Suppression of alpha-synuclein toxicity and vesicle trafficking defects by phosphorylation at S129 in yeast depends on genetic context","volume":"21","author":"Sancenon","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jbc.2021.100273_bib12","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.neulet.2014.01.033","article-title":"Transgenic mice expressing S129 phosphorylation mutations in alpha-synuclein","volume":"563","author":"Escobar","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jbc.2021.100273_bib13","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.nbd.2015.03.008","article-title":"Ser129 phosphorylation of endogenous alpha-synuclein induced by overexpression of polo-like kinases 2 and 3 in nigral dopamine neurons is not detrimental to their survival and function","volume":"78","author":"Buck","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jbc.2021.100273_bib14","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/nn1443","article-title":"Alpha-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease","volume":"8","author":"Chen","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jbc.2021.100273_bib15","doi-asserted-by":"crossref","first-page":"23179","DOI":"10.1074\/jbc.M802223200","article-title":"Serine 129 phosphorylation of alpha-synuclein induces unfolded protein response-mediated cell death","volume":"283","author":"Sugeno","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2021.100273_bib16","first-page":"3257","article-title":"Tyrosine and serine phosphorylation of alpha-synuclein have opposing effects on neurotoxicity and soluble oligomer formation","volume":"119","author":"Chen","year":"2009","journal-title":"J.\u00a0Clin. Invest"},{"key":"10.1016\/j.jbc.2021.100273_bib17","doi-asserted-by":"crossref","first-page":"6963","DOI":"10.1523\/JNEUROSCI.6513-10.2011","article-title":"Enhanced phosphatase activity attenuates alpha-synucleinopathy in a mouse model","volume":"31","author":"Lee","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.jbc.2021.100273_bib18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.nbd.2013.03.014","article-title":"Ser129D mutant alpha-synuclein induces earlier motor dysfunction while S129A results in distinctive pathology in a rat model of Parkinson's disease","volume":"56","author":"Febbraro","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jbc.2021.100273_bib19","doi-asserted-by":"crossref","first-page":"16533","DOI":"10.1038\/s41598-017-15813-8","article-title":"Phosphorylated exogenous alpha-synuclein fibrils exacerbate pathology and induce neuronal dysfunction in mice","volume":"7","author":"Karampetsou","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2021.100273_bib20","doi-asserted-by":"crossref","first-page":"16884","DOI":"10.1523\/JNEUROSCI.3967-11.2011","article-title":"Authentically phosphorylated alpha-synuclein at Ser129 accelerates neurodegeneration in a rat model of familial Parkinson's disease","volume":"31","author":"Sato","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.jbc.2021.100273_bib21","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1432-1033.1993.tb18337.x","article-title":"A\u00a0new brain-specific 14-kDa protein is a phosphoprotein. Its complete amino acid sequence and evidence for phosphorylation","volume":"217","author":"Nakajo","year":"1993","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.jbc.2021.100273_bib22","doi-asserted-by":"crossref","first-page":"26515","DOI":"10.1074\/jbc.M003542200","article-title":"Synucleins are a novel class of substrates for G protein-coupled receptor kinases","volume":"275","author":"Pronin","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2021.100273_bib23","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1074\/jbc.C800206200","article-title":"Polo-like kinase 2 (PLK2) phosphorylates alpha-synuclein at serine 129 in central nervous system","volume":"284","author":"Inglis","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2021.100273_bib24","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1074\/jbc.275.1.390","article-title":"Constitutive phosphorylation of the Parkinson's disease associated alpha-synuclein","volume":"275","author":"Okochi","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2021.100273_bib25","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/NEN.0b013e3186fc995","article-title":"Specificity and regulation of casein kinase-mediated phosphorylation of alpha-synuclein","volume":"67","author":"Waxman","year":"2008","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.jbc.2021.100273_bib26","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1074\/jbc.M109.081950","article-title":"Phosphorylation of synucleins by members of the Polo-like kinase family","volume":"285","author":"Mbefo","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2021.100273_bib27","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.bbrc.2009.04.130","article-title":"Contribution of endogenous G-protein-coupled receptor kinases to Ser129 phosphorylation of alpha-synuclein in HEK293 cells","volume":"384","author":"Sakamoto","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jbc.2021.100273_bib28","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/jnr.22537","article-title":"Characterization of kinases involved in the phosphorylation of aggregated alpha-synuclein","volume":"89","author":"Waxman","year":"2011","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.jbc.2021.100273_bib29","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1007\/s12035-013-8473-z","article-title":"PLK2 modulates alpha-synuclein aggregation in yeast and mammalian cells","volume":"48","author":"Basso","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jbc.2021.100273_bib30","doi-asserted-by":"crossref","first-page":"121ra120","DOI":"10.1126\/scitranslmed.3002566","article-title":"Phosphorylated alpha-synuclein in Parkinson's disease","volume":"4","author":"Wang","year":"2012","journal-title":"Sci. Transl Med."},{"key":"10.1016\/j.jbc.2021.100273_bib31","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/cmdc.201300166","article-title":"Selective and brain-permeable polo-like kinase-2 (Plk-2) inhibitors that reduce alpha-synuclein phosphorylation in rat brain","volume":"8","author":"Aubele","year":"2013","journal-title":"ChemMedChem"},{"key":"10.1016\/j.jbc.2021.100273_bib32","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neuroscience.2013.09.061","article-title":"In\u00a0vivo modulation of polo-like kinases supports a key role for PLK2 in Ser129 alpha-synuclein phosphorylation in mouse brain","volume":"256","author":"Bergeron","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.jbc.2021.100273_bib33","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/jnr.20446","article-title":"Lysosomal pathology associated with alpha-synuclein accumulation in transgenic models using an eGFP fusion protein","volume":"80","author":"Rockenstein","year":"2005","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.jbc.2021.100273_bib34","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.celrep.2015.01.060","article-title":"Progressive aggregation of alpha-synuclein and selective degeneration of lewy inclusion-bearing neurons in a mouse model of parkinsonism","volume":"10","author":"Osterberg","year":"2015","journal-title":"Cell Rep"},{"key":"10.1016\/j.jbc.2021.100273_bib35","doi-asserted-by":"crossref","first-page":"e10589","DOI":"10.1371\/journal.pone.0010589","article-title":"In\u00a0vivo imaging of alpha-synuclein in mouse cortex demonstrates stable expression and differential subcellular compartment mobility","volume":"5","author":"Unni","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2021.100273_bib36","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1523\/JNEUROSCI.2581-13.2014","article-title":"Presynaptic alpha-synuclein aggregation in a mouse model of Parkinson's disease","volume":"34","author":"Spinelli","year":"2014","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.jbc.2021.100273_bib37","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s40478-020-01026-0","article-title":"Trans-synaptic and retrograde axonal spread of Lewy pathology following pre-formed fibril injection in an in\u00a0vivo A53T alpha-synuclein mouse model of synucleinopathy","volume":"8","author":"Schaser","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.jbc.2021.100273_bib38","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1747-0285.2007.00594.x","article-title":"Selectivity-determining residues in Plk1","volume":"70","author":"Kothe","year":"2007","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.jbc.2021.100273_bib39","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.cub.2006.12.037","article-title":"BI 2536, a potent and selective inhibitor of polo-like kinase 1, inhibits tumor growth in\u00a0vivo","volume":"17","author":"Steegmaier","year":"2007","journal-title":"Curr. Biol."},{"key":"10.1016\/j.jbc.2021.100273_bib40","doi-asserted-by":"crossref","first-page":"9551","DOI":"10.1021\/bi7008745","article-title":"Pharmacological and functional comparison of the polo-like kinase family: Insight into inhibitor and substrate specificity","volume":"46","author":"Johnson","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2021.100273_bib41","doi-asserted-by":"crossref","first-page":"E3945","DOI":"10.1073\/pnas.1309991110","article-title":"Polo-like kinase 2 regulates selective autophagic alpha-synuclein clearance and suppresses its toxicity in\u00a0vivo","volume":"110","author":"Oueslati","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"10.1016\/j.jbc.2021.100273_bib42","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.nbd.2017.06.014","article-title":"Polo-like kinase 2 modulates alpha-synuclein protein levels by regulating its mRNA production","volume":"106","author":"Kofoed","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jbc.2021.100273_bib43","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s12035-013-8406-x","article-title":"Assessing the subcellular dynamics of alpha-synuclein using photoactivation microscopy","volume":"47","author":"Goncalves","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jbc.2021.100273_bib44","doi-asserted-by":"crossref","first-page":"10919","DOI":"10.1038\/s41598-019-47227-z","article-title":"Alpha-synuclein is a DNA binding protein that modulates DNA repair with implications for Lewy body disorders","volume":"9","author":"Schaser","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2021.100273_bib45","first-page":"51863","article-title":"Intracerebroventricular viral injection of the neonatal mouse brain for persistent and widespread neuronal transduction","volume":"91","author":"Kim","year":"2014","journal-title":"J.\u00a0Vis. Exp."},{"key":"10.1016\/j.jbc.2021.100273_bib46","doi-asserted-by":"crossref","first-page":"8466","DOI":"10.18632\/oncotarget.6445","article-title":"Age- and brain region-dependent alpha-synuclein oligomerization is attributed to alterations in intrinsic enzymes regulating alpha-synuclein phosphorylation in aging monkey brains","volume":"7","author":"Chen","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbc.2021.100273_bib47","doi-asserted-by":"crossref","first-page":"8083","DOI":"10.1523\/JNEUROSCI.1091-10.2010","article-title":"A\u00a0pathologic cascade leading to synaptic dysfunction in alpha-synuclein-induced neurodegeneration","volume":"30","author":"Scott","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.jbc.2021.100273_bib48","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1523\/JNEUROSCI.4564-06.2007","article-title":"Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies","volume":"27","author":"Kramer","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.jbc.2021.100273_bib49","doi-asserted-by":"crossref","first-page":"36575","DOI":"10.1074\/jbc.M504548200","article-title":"Polo-like kinase 1-mediated phosphorylation stabilizes Pin1 by inhibiting its ubiquitination in human cells","volume":"280","author":"Eckerdt","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2021.100273_bib50","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/sj.onc.1208277","article-title":"Polo-like kinases in the nervous system","volume":"24","author":"Seeburg","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.jbc.2021.100273_bib51","doi-asserted-by":"crossref","first-page":"16895","DOI":"10.1074\/jbc.M800747200","article-title":"Phosphorylation at Ser-129 but not the phosphomimics S129E\/D inhibits the fibrillation of alpha-synuclein","volume":"283","author":"Paleologou","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2021.100273_bib52","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejca.2011.11.001","article-title":"A\u00a0phase I, dose-escalation study of the novel Polo-like kinase inhibitor volasertib (BI 6727) in patients with advanced solid tumours","volume":"48","author":"Schoffski","year":"2012","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jbc.2021.100273_bib53","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/hmg\/ddy326","article-title":"Nuclear localization and phosphorylation modulate pathological effects of alpha-synuclein","volume":"28","author":"Pinho","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jbc.2021.100273_bib54","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: An open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.jbc.2021.100273_bib55","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/jnc.13737","article-title":"Genotype differences in anxiety and fear learning and memory of WT and ApoE4 mice associated with enhanced generation of hippocampal reactive oxygen species","volume":"138","author":"Villasana","year":"2016","journal-title":"J.\u00a0Neurochem."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925821000405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925821000405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,17]],"date-time":"2021-10-17T03:03:04Z","timestamp":1634439784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925821000405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":55,"alternative-id":["S0021925821000405"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2021.100273","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic deletion of Polo-like kinase 2 reduces alpha-synuclein serine-129 phosphorylation in presynaptic terminals but not Lewy bodies","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2021.100273","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"100273"}}